440 related articles for article (PubMed ID: 32883226)
21. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
22. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
23. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
[TBL] [Abstract][Full Text] [Related]
24. High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.
Yu X; Chen C; Hu Y; Li K; Zhang Y; Chen Z; Nie D; Gao R; Huang Y; Zhong M; Wang C; Wang S; Zeng Y; Li Y; Zeng C
Cancer Med; 2023 Apr; 12(7):9055-9067. PubMed ID: 36708053
[TBL] [Abstract][Full Text] [Related]
25. Exploring the major cross-talking edges of competitive endogenous RNA networks in human Chronic and Acute Myeloid Leukemia.
Sen K; Bhattacharyya D; Sarkar A; Das J; Maji N; Basu M; Ghosh Z; Ghosh TC
Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1883-1892. PubMed ID: 29902552
[TBL] [Abstract][Full Text] [Related]
26. Revealing key lncRNAs in cytogenetically normal acute myeloid leukemia by reconstruction of the lncRNA-miRNA-mRNA network.
Sun T; Dong L; Guo Y; Zhao H; Wang M
Sci Rep; 2022 Mar; 12(1):4973. PubMed ID: 35322118
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Luo Q; Cui M; Deng Q; Liu J
Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
[TBL] [Abstract][Full Text] [Related]
28. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
Li Y; Kan X
Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
[TBL] [Abstract][Full Text] [Related]
31. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
32. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
33. To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
Jiang J; Bi Y; Liu XP; Yu D; Yan X; Yao J; Liu T; Li S
J Cell Mol Med; 2020 May; 24(9):5375-5386. PubMed ID: 32233022
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
Wang Y; Li Y; Song HQ; Sun GW
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a 10-gene prognostic signature for acute myeloid leukaemia.
Yang Z; Shang J; Li N; Zhang L; Tang T; Tian G; Chen X
J Cell Mol Med; 2020 Apr; 24(8):4510-4523. PubMed ID: 32150667
[TBL] [Abstract][Full Text] [Related]
36. Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.
Xie J; Chen K; Han H; Dong Q; Wang W
Curr Res Transl Med; 2022 Sep; 70(4):103347. PubMed ID: 35483237
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA Maternally Expressed Gene 3 Is Downregulated, and Its Insufficiency Correlates With Poor-Risk Stratification, Worse Treatment Response, as Well as Unfavorable Survival Data in Patients With Acute Myeloid Leukemia.
He C; Wang X; Luo J; Ma Y; Yang Z
Technol Cancer Res Treat; 2020; 19():1533033820945815. PubMed ID: 32720591
[TBL] [Abstract][Full Text] [Related]
38. Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks.
Zhang H; Zhuo C; Zhou D; Zhang M; Zhang F; Chen M; Xu S; Chen Z
Med Sci Monit; 2020 Feb; 26():e920482. PubMed ID: 32036380
[TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
Tuersong T; Li L; Abulaiti Z; Feng S
Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]